Notice of updates

We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.

Read FSG

icon
HALO logo
halo search icon
Novo Nordisk A/S Sponsored ADR Class B

US$46.59

Price Change Indicator
0.00 (0.00%)
Novo Nordisk A/S Sponsored ADR Class B
0TDD · LON

Novo Nordisk A/S Sponsored ADR Class B

Start Trading 0TDD for Free

US$46.59

0.00 (0.00%)
10/12/2025 12:00:00 AM
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Novo Nordisk A/S Sponsored ADR Class B Overview

0TDD Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About 0TDD

icon

Website

Novo Nordisk A/S Sponsored ADR Class B

icon

Telephone

45.44.44.88.88

icon

Address

Novo Allé 1, Bagsværd, Capital Region 2880

Description

N/A

0TDD Price Chart

Key Stats

Market Cap

US$444.05B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

N/A

Ex Dividend Date (est.)

18-Aug-25

Market Data

52 weeks range

Low 41.45 - 112.5

Trade Value (12mth)

US$2,144,424.00

1 week

-2.52%

1 month

2.23%

YTD

-46.25%

1 year

-57.74%

All time high

149.80

Key Fundamentals

EPS 3 yr Growth

99.00%

EBITDA Margin

50.90%

Operating Cashflow

$17,543m

Free Cash Flow Return

68.50%

ROIC

57.20%

Interest Coverage

76.70

Quick Ratio

0.60

Other Data

Shares Outstanding (Fully Diluted)

4,447m

HALO Sector

Healthcare

Next Company Report Date

N/A

Next Ex Dividend Date

18-Aug-25

Next Dividend Pay Date

26-Aug-25

Reporting Currency

USD

Short Sell (% of issue)

0.00

0TDD Fundamentals

Per Share Records

Historical data

Forecast data

2020202120222023202220232024202520262027
Per Share, Growth & Valuations
EPS (Basic)
 GBPlocklocklocklock1.732.713.29locklocklock
EPS (Fully Diluted)
 GBPlocklocklocklock1.732.73.28locklocklock
Growth
 %locklocklocklock4.856.421.4locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

18-Aug-25

DIV Yield

N/A

Franking Level

N/A

DPSg

21.1%

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Want to learn more?Frequently asked questions.
What is the current share price of Novo Nordisk A/S Sponsored ADR Class B (0TDD:LON)?
Halo FAQ
The current share price of Novo Nordisk A/S Sponsored ADR Class B (0TDD:LON) is USD$46.59.
What is the 52-week high share price for Novo Nordisk A/S Sponsored ADR Class B (0TDD:LON)?
Halo FAQ
The 52-week high share price for Novo Nordisk A/S Sponsored ADR Class B (0TDD:LON) is USD$112.50.
What is the 52-week low share price for Novo Nordisk A/S Sponsored ADR Class B (0TDD:LON)?
Halo FAQ
The 52-week low share price for Novo Nordisk A/S Sponsored ADR Class B (0TDD:LON) is USD$41.45.
What is the dividend yield for Novo Nordisk A/S Sponsored ADR Class B (0TDD:LON)?
Halo FAQ
Novo Nordisk A/S Sponsored ADR Class B (0TDD:LON) does not pay a dividend.
What was Novo Nordisk A/S Sponsored ADR Class B (0TDD:LON) last dividend payment?
Halo FAQ
The last dividend payment of Novo Nordisk A/S Sponsored ADR Class B (0TDD:LON) is USD$0.41.
What is the franking level for Novo Nordisk A/S Sponsored ADR Class B (0TDD:LON)?
Halo FAQ
Novo Nordisk A/S Sponsored ADR Class B (0TDD:LON) has a franking level of 0.00%.
In which sector is Novo Nordisk A/S Sponsored ADR Class B (0TDD:LON) classified?
Halo FAQ
Novo Nordisk A/S Sponsored ADR Class B (0TDD:LON) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial